Enzymes maker Novozymes plans to acquire TJ Innovation, a South Dakota bioagriculture company in a move to bolster its own abilities to provide sustainable agricultural products.

Novozymes said the agricultural industry faces the challenge of increasing crop yields in ways that are economically and environmentally sustainable. TJ Technologies makes bioyield enhancers, products that are derived from plants and microorganisms that improve crops’ growth, stress tolerance and yield. The TJ Technologies bioyield enhancers, which generate close to $15 million in annual revenue for the Watertown, S.D. company, now join Novozymes own portfolio of bioyield enhancer products.

“TJ Technologies Inc. is a front runner in bioyield enhancers, and this acquisition will further underpin Novozymes’ position with complementary and capable products, while strengthening commercial access,” Thomas Videbæk, executive vice president of Novozymes and head of business development said in a statement.

Denmark-based Novozymes operates its North American headquarters in Franklinton, where the company makes enzymes used in an array of applications ranging from industrial uses to biofuel production. Novozymes did not disclose any financial terms of the acquisition of privately-held TJ Technologies but said that it would not impact the company’s financial guidance for 2013, nor does it have a material impact on 2013 group sales and earnings. The deal is expected to close within the next week.

TJ Technologies was founded in 1978. The companies proprietary microbial and micronutrient products for agriculture are used in seed treatment of corn, as well as other crops such as soy and wheat.